 BURLINGAME, Calif., March 05, 2021 GLOBE NEWSWIRE -- Corvus Pharmaceuticals, Inc. NASDAQ: CRVS, a clinical-stage biopharmaceutical company, today announced that the Companys management will participate in two upcoming investor conferences in March: 